Last-year-of-life expenditure of patients diagnosed with cancer
DOI:
https://doi.org/10.35509/01239015.169Keywords:
Health services, Terminal care, DeathAbstract
Objective: To estimate last-year-of-life expenditure for patients diagnosed with cancer in Colombia.
Methods: This is a descriptive retrospective study. Using claims data for two HMO for years 2011- 2013, last-year-of-life expenditure was estimated for all persons dying in 2012-2013. Cancer diagnoses were identified using ICD-10 codes. Last-year-of-life expenditure was defined as allservices provided between the date of death and the 360 days previous.
Results: A cancer diagnosis was recorded in 30.4% of the deceased and accounted for 43.6% of total last-year-of-life expenditure in 2012, and 40% in 2013. The mean per deceased expenditure was between 72% and 76% higher for patients with cancer as compared to patients without cancer. Last-year-of-life expenditure increases with the proximity to death.
Conclusion: The use of resources for people dying with cancer diagnosis could be reduced with palliative care programs that give patients a quality of life.
Author Biographies
Sergio I. Prada, Universidad Icesi
Centro PROESA, Universidad Icesi, Cali, Colombia
Juan F. Contreras, Universidad Icesi
Centro PROESA, Universidad Icesi, Cali, Colombia
References
Organización Mundial de la Salud. International Agency on Research of Cancer. http://gco.iarc.fr/today/data/pdf/factsheets/cancers/cancer-fact-sheets-29.pdf.Published2012.
Departamento Administrativo Nacional de Estadísticas (DANE). Estadísticas por tema: Demografía y población [internet]. Bogotá: 2017. https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion
Tobar F. Economía de los medicamentos genéricos en América Latina. Rev Panam Salud Publica. 2008;23:59-67.
https://doi.org/10.1590/S1020-49892008000100008
Siddiqui M, Rajkumar SV. The high cost of cancer drugs and what we can do about it. Mayo Clin Proc. 2012;87:935-43.
https://doi.org/10.1016/j.mayocp.2012.07.007
Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933-80.
https://doi.org/10.1016/S1470-2045(11)70141-3
Round J, Jones L, Morris S. Estimating the cost of caring for people with cancer at the end of life: A modelling study. Palliat Med. 2015;29:899-907.
https://doi.org/10.1177/0269216315595203
Guest JF, Ruiz FJ, Greener MJ, Trotman IF. Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK. Eur J Cancer Care (Engl). 2006;15:65-73.
https://doi.org/10.1111/j.1365-2354.2005.00623.x
American Cancer Society. The global economic cost of cancer. 2010.
Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14:1165-74.
https://doi.org/10.1016/S1470-2045(13)70442-X
Machado Alba JE, Moncada Escobar JC. Evolución del consumo de medicamentos de alto costo en Colombia. Rev Panam Salud Pública. 2012;31:283-9.
https://doi.org/10.1590/S1020-49892012000400003
Gamboa Ó, Buitrago L, Lozano T, Dieleman S, Gamboa C, León Guzmán É, et al. Costos directos de la atención del cáncer de mama en Colombia. Rev Colomb Cancerol. 2016;20:52-60.
https://doi.org/10.1016/j.rccan.2016.02.003
Gaviria A, Cubillos LA. Costos médicos directos en el tratamiento de cáncer gástrico en los estadios 0 A IIIB en pacientes adultos en Colombia [Trabajo de grado]. Bogotá: U.D.C.A; 2015.
Lubitz JD, Riley GF. Trends in medicare payments in the last year of life. N Engl J Med. 1993;328:1092-6.
https://doi.org/10.1056/NEJM199304153281506
Riley GF, Lubitz JD. Long-term trends in medicare payments in the last year of life. Health Serv Res. 2010;45:565-76.
https://doi.org/10.1111/j.1475-6773.2010.01082.x
Georghiou T, Bardsley M. Exploring the cost of care at the end of life. Nuffield Trust. 2014. https://www.nuffieldtrust.org.uk/research/exploring-the-cost-of-care-at-the-end-of-life
Chastek B, Harley C, Kallich J, Newcomer L, Paoli CJ, Teitelbaum AH. Health care costs for patients with cancer at the end of life. J Oncol Pract. 2012;8:75-80.
https://doi.org/10.1200/JOP.2011.000469
Hwang I, Shin DW, Kang KH, Yang HK, Kim SY, Park JH. Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009. Cancer Res Treat. 2016;48:365-75.
https://doi.org/10.4143/crt.2014.088
Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, et al. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. Jama. 2016;315:272.
https://doi.org/10.1001/jama.2015.18603
Billings JA. Palliative care. BMJ. 2000;321:555-8.
https://doi.org/10.1136/bmj.321.7260.555
Medicare. No Title. https://es.medicare.gov/what-medicarecovers/part-a/how-hospice-works.html
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
